Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Goodall

Showing results (61-70 of 83) with videos related to

Pageof 9
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)|May 28, 2010
Lack of minority K65R-resistant viral populations detected after repeated treatment interruptions of tenofovir/zidovudine and lamivudine in a resource-limited settingAdele L McCormick, Ruth L Goodall, Aengus Joyce, et al.
HIV Medicine|May 24, 2011
Hyperlactataemia in HIV-infected subjects initiating antiretroviral therapy in a large randomized study (a substudy of the INITIO trial)E R Feeney, C Chazallon, N O'Brien, et al.
Nanoscale|April 5, 2014
Chirality effects at each amino acid position on tripeptide self-assembly into hydrogel biomaterialsS Marchesan, C D Easton, K E Styan, et al.
Antimicrobial Agents and Chemotherapy|February 2, 2011
Impact of the N348I mutation in HIV-1 reverse transcriptase on nonnucleoside reverse transcriptase inhibitor resistance in non-subtype B HIV-1Adele L McCormick, Chris M Parry, Anne Crombe, et al.
The Journal of Antimicrobial Chemotherapy|February 5, 2017
Rapid accumulation of HIV-1 thymidine analogue mutations and phenotypic impact following prolonged viral failure on zidovudine-based first-line ART in sub-Saharan AfricaRuth L Goodall, David T Dunn, Peter Nkurunziza, et al.
Developmental Cell|May 25, 2016
The Autophagy Machinery Controls Cell Death Switching between Apoptosis and NecroptosisMegan L Goodall, Brent E Fitzwalter, Shadi Zahedi, et al.
Plos One|February 26, 2013
A single CD4 test with 250 cells/mm3 threshold predicts viral suppression in HIV-infected adults failing first-line therapy by clinical criteriaCharles F Gilks, A Sarah Walker, Paula Munderi, et al.
BMC Medicine|November 4, 2020
Investigation of the efficacy of the short regimen for rifampicin-resistant TB from the STREAM trialP P J Phillips, A Van Deun, S Ahmed, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|July 28, 2022
Failure or relapse predictors for the STREAM Stage 1 short regimen for RR-TBD M Kokebu, S Ahmed, R Moodliar, et al.
Plos One|March 15, 2014
High level of viral suppression and low switch rate to second-line antiretroviral therapy among HIV-infected adult patients followed over five years: retrospective analysis of the DART trialCissy Kityo, Diana M Gibb, Charles F Gilks, et al.
Pageof 9

Showing results (61-70 of 83) with videos related to

Sort By:
Pageof 9
Journal of Acquired Immune Deficiency Syndromes (1999)|May 28, 2010
Lack of minority K65R-resistant viral populations detected after repeated treatment interruptions of tenofovir/zidovudine and lamivudine in a resource-limited settingAdele L McCormick, Ruth L Goodall, Aengus Joyce, et al.
HIV Medicine|May 24, 2011
Hyperlactataemia in HIV-infected subjects initiating antiretroviral therapy in a large randomized study (a substudy of the INITIO trial)E R Feeney, C Chazallon, N O'Brien, et al.
Nanoscale|April 5, 2014
Chirality effects at each amino acid position on tripeptide self-assembly into hydrogel biomaterialsS Marchesan, C D Easton, K E Styan, et al.
Antimicrobial Agents and Chemotherapy|February 2, 2011
Impact of the N348I mutation in HIV-1 reverse transcriptase on nonnucleoside reverse transcriptase inhibitor resistance in non-subtype B HIV-1Adele L McCormick, Chris M Parry, Anne Crombe, et al.
The Journal of Antimicrobial Chemotherapy|February 5, 2017
Rapid accumulation of HIV-1 thymidine analogue mutations and phenotypic impact following prolonged viral failure on zidovudine-based first-line ART in sub-Saharan AfricaRuth L Goodall, David T Dunn, Peter Nkurunziza, et al.
Developmental Cell|May 25, 2016
The Autophagy Machinery Controls Cell Death Switching between Apoptosis and NecroptosisMegan L Goodall, Brent E Fitzwalter, Shadi Zahedi, et al.
Plos One|February 26, 2013
A single CD4 test with 250 cells/mm3 threshold predicts viral suppression in HIV-infected adults failing first-line therapy by clinical criteriaCharles F Gilks, A Sarah Walker, Paula Munderi, et al.
BMC Medicine|November 4, 2020
Investigation of the efficacy of the short regimen for rifampicin-resistant TB from the STREAM trialP P J Phillips, A Van Deun, S Ahmed, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|July 28, 2022
Failure or relapse predictors for the STREAM Stage 1 short regimen for RR-TBD M Kokebu, S Ahmed, R Moodliar, et al.
Plos One|March 15, 2014
High level of viral suppression and low switch rate to second-line antiretroviral therapy among HIV-infected adult patients followed over five years: retrospective analysis of the DART trialCissy Kityo, Diana M Gibb, Charles F Gilks, et al.
Pageof 9